Integrum AB Series B
Research Integrum AB Series B (INTEG-B) on Bullrun: market cap SEK 212.28M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINTEG-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 212.28M
- Financial periodQ1 2026
- RevenueSEK 20.20M
- Net income-SEK 11.47M
- Free cash flow-SEK 18.64M
- Gross margin71.8%
Valuation Snapshot
latest market cap is SEK 212.28M.
About Integrum AB Series B
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.
Frequently asked questions
What is Integrum AB Series B's market cap?
Integrum AB Series B's market capitalization is SEK 212.28M.
What does Integrum AB Series B do?
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the...